Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network (Q44135718)

From Wikidata

Jump to navigation Jump to search

scientific article published in October 2005

Language	Label	Description	Also known as
English	Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network	scientific article published in October 2005

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

0 references

mantle cell lymphoma

1 reference

based on heuristic

inferred from title

object named as

Elias Campo

5

0 references

Martin Dreyling

4

object named as

Martin H Dreyling

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Michael Unterhalt

19

object named as

Michael Unterhalt

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

author name string

Markus Tiemann

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Carsten Schrader

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Wolfram Klapper

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Andrew Norton

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Francoise Berger

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Philip Kluin

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

German Ott

9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Stephano Pileri

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Ennio Pedrinis

11

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Alfred C Feller

12

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Hartmut Merz

13

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Dirk Janssen

14

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Martin L Hansmann

15

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Han Krieken

16

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Peter Möller

17

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Harald Stein

18

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Wolfgang Hiddemann

20

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Reza Parwaresch

21

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

European MCL Network

22

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 October 2005

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

131

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

29-38

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Clinical and prognostic relevance of the Kiel classification of non-Hodgkin lymphomas results of a prospective multicenter study by the Kiel Lymphoma Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Early consolidation by myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission significantly prolongs progression-free survival in mantle-cell lymphoma: results of a prospective randomized trial of the Eur

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Mantle cell lymphoma: established therapeutic options and future directions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Moderate increase of secondary hematologic malignancies after myeloablative radiochemotherapy and autologous stem-cell transplantation in patients with indolent lymphoma: results of a prospective randomized trial of the German Low Grade Lymphoma Stu

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

The cytomorphological spectrum of mantle cell lymphoma is reflected by distinct biological features

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Ki-67 expression level, histological subtype, and the International Prognostic Index as outcome predictors in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Topoisomerase IIalpha expression in mantle cell lymphoma: a marker of cell proliferation and a prognostic factor for clinical outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Morphological and immunological definition of a malignant lymphoma derived from germinal-centre cells with cleaved nuclei (centrocytes).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Large-cell variants of mantle cell lymphoma: cytologic characteristics and p53 anomalies may predict poor outcome.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2005.05716.X

21 January 2018

Identifiers

10.1111/J.1365-2141.2005.05716.X

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44135718&oldid=2218509552"